Bevacizumab in the neoadjuvant treatment of human epidermal growth factor receptor 2-negative breast cancer: A meta-analysis of randomized controlled trials

Por Nahleh, Zeina, Botrus, Gehan, Dwivedi, Alok, Jennings, Michael, Nagy, Shaimaa, Tfayli, Arafat
Publicado no Mol Clin Oncol (2019)